<DOC>
	<DOCNO>NCT01062724</DOCNO>
	<brief_summary>The purpose study analyze infant receive Primene solution , low serum level methionine cysteine high serum level taurine , also analyze infant receive Primene solution develop TPN-associated cholestasis small proportion receive Trophamine solution .</brief_summary>
	<brief_title>Total Parenteral Nutrition Associated Cholestasis ( TPNAC ) Plasma Amino Acid Levels Neonates</brief_title>
	<detailed_description>Total parenteral nutrition essential component care premature ill infant . Prolonged parenteral nutrition associate complication affect hepatobiliary system , cholelithiasis , cholestasis , steatosis . The common total parenteral nutrition-associated cholestasis ( TPNAC ) , occur reduce bile flow liver duodenum . Cholestasis cause liver damage case , death . Infant neonate particular risk complication . The incidence TPNAC range 7.4 84 % . Animal study implicate amino acid production cholestasis ; whereas study human neonates suggest direct effect amino acid infusion hepatocyte canalicular membrane . An appropriate amino acid solution might compensate metabolic immaturity infant perhaps reduce total parenteral nutrition associate complication cholestasis . Therefore , important compare frequency cholestasis blood amino acid concentration Primene Trophamine use .</detailed_description>
	<mesh_term>Cholestasis</mesh_term>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Amino-acid , glucose , electrolyte solution</mesh_term>
	<criteria>Newborns great 1500 g enter Intensive Care Unit pathology require total parenteral nutritional support ( necrotizing enterocolitis , intestinal atresia , short bowel syndrome ) . Gestational age great 30 week Patients normal liver function test age , prior initiation total parenteral nutrition . Authorization parent legal guardian recruiting child study consent sign form purpose procedure explain Patients acute renal failure Congenital liver disease , endstage liver disease Patients liver damage secondary viral bacterial infection Patients liver damage secondary drug</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>28 Days</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Cholestasis</keyword>
	<keyword>TPN</keyword>
	<keyword>Neonates</keyword>
	<keyword>Primene</keyword>
	<keyword>Trophamine</keyword>
	<keyword>Methionine</keyword>
	<keyword>Cysteine</keyword>
	<keyword>Taurine</keyword>
	<keyword>Total Parenteral Nutrition</keyword>
</DOC>